Australian researchers develop blood test to detect early-stage lung cancer

Lung cancer claims approximately 9,000 lives annually in Australia, making early detection critical for improving patient survival outcomes.

Each year, lung cancer quietly claims nearly 9,000 Australian lives — not always because treatment arrives too late, but because diagnosis itself takes too long. Researchers at the University of Queensland have designed a nanodevice that reads molecular sugar codes on particles floating in a single drop of blood, distinguishing cancerous tissue from healthy cells before the disease has time to entrench itself. In doing so, they have not merely improved a test — they have challenged the assumption that early detection must be slow, expensive, and invasive.

Australian researchers develop blood test to detect early-stage lung cancer

Cobertura Relacionada

Receba o Register no seu e-mail